Literature DB >> 9781020

Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF).

M Dewalle1, C Domingo, M Rozenbaum, E Ben-Chétrit, D Cattan, A Bernot, C Dross, M Dupont, C Notarnicola, M Levy, I Rosner, J Demaille, I Touitou.   

Abstract

Familial Mediterranean Fever is one of the most frequent recessive disease in non-Ashkenazi Jews. The gene responsible for the disease (MEFV) has very recently been identified. The M694V ('MED') mutation was found in about 80% of the FMF Jewish (Iraqi and North African) chromosomes. To see if the presence of this mutation could be correlated with particular traits of the disease, we examined a number of clinical features in a panel of 109 Jewish FMF patients with 0, 1 or 2 MED mutations. We showed that homozygosity for this mutation was significantly associated with a more severe form of the disease. In homozygous patients, the disease started earlier (mean age 6.4 +/- 5 vs 13.6 +/- 8.9) and both arthritis and pleuritis were twice as frequent as in patients with one or no M694V mutation. Moreover, 3/3 patients with amyloidosis displayed two MED mutations. No association was found with fever, peritonitis, response to colchicine and erysipeloid eruption. The present result strongly suggests the potential prognostic value of the presence of this mutation.

Entities:  

Mesh:

Year:  1998        PMID: 9781020     DOI: 10.1038/sj.ejhg.5200170

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  26 in total

1.  Familial Mediterranean fever in Syrian children: phenotype-genotype correlation.

Authors:  Rami A Jarjour; Sumaya Al-Berrawi
Journal:  Rheumatol Int       Date:  2014-08-24       Impact factor: 2.631

2.  Amyloidosis induced, end stage renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV gene.

Authors:  E Ben-Chetrit; R Backenroth
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

3.  Predictors of AA amyloidosis in familial Mediterranean fever.

Authors:  Nikolay A Mukhin; Lidiya V Kozlovskaya; Marina V Bogdanova; Vilen V Rameev; Sergey V Moiseev; Armine Kh Simonyan
Journal:  Rheumatol Int       Date:  2015-01-14       Impact factor: 2.631

4.  Association of clinical and genetical features in FMF with focus on MEFV strip assay sensitivity in 452 children from western Anatolia, Turkey.

Authors:  Can Ozturk; Oya Halicioglu; Işil Coker; Nesrin Gulez; Sumer Sutçuoglu; Neslihan Karaca; Guzide Aksu; Necil Kutukculer
Journal:  Clin Rheumatol       Date:  2011-11-05       Impact factor: 2.980

5.  Familial Mediterranean fever gene mutation frequencies and genotype-phenotype correlations in the Aegean region of Turkey.

Authors:  Elif Ozalkaya; Sevgi Mir; Betul Sozeri; Afig Berdeli; Fatma Mutlubas; Alphan Cura
Journal:  Rheumatol Int       Date:  2010-03-09       Impact factor: 2.631

Review 6.  Familial Mediterranean fever.

Authors:  Aysin Bakkaloglu
Journal:  Pediatr Nephrol       Date:  2003-06-27       Impact factor: 3.714

7.  MEFV mutations in Egyptian patients suffering from familial Mediterranean fever: analysis of 12 gene mutations.

Authors:  Ayman el-Garf; Samia Salah; Iman Iskander; Hala Salah; Sherif Naseh Amin
Journal:  Rheumatol Int       Date:  2009-09-24       Impact factor: 2.631

8.  A comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis.

Authors:  Ayse Cefle; Sevil Kamali; Mehmet Sayarlioglu; Murat Inanc; Lale Ocal; Orhan Aral; Meral Konice; Ahmet Gul
Journal:  Rheumatol Int       Date:  2004-07-30       Impact factor: 2.631

9.  MEFV mutations in familial Mediterranean fever: association of M694V homozygosity with arthritis.

Authors:  Abdullah Olgun; Serif Akman; Ismail Kurt; Ahmet Tuzun; Turker Kutluay
Journal:  Rheumatol Int       Date:  2004-01-15       Impact factor: 2.631

10.  The evaluation of carotid intima-media thickness in children with familial Mediterranean fever.

Authors:  Harun Peru; Bülent Altun; Mustafa Doğan; Fatih Kara; Ahmet Midhat Elmaci; Bülent Oran
Journal:  Clin Rheumatol       Date:  2007-10-10       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.